[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368092-105":59,"doc-detail-368092-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","hydroxybutyrate-a-ketone-body-suppresses-tumor-growth-stemness-and-invasive-phenotypes-in-non-small-cell-lung-cancer","β-hydroxybutyrate, a ketone body, suppresses tumor growth, stemness, and invasive phenotypes in non-small cell lung cancer","","Beta-hydroxybutyrate (BHB), a ketone body, is studied for its role in non-small cell lung cancer (NSCLC) progression. Using CCK-8, flow cytometry, western blotting and Transwell assays, the work evaluates BHB effects on NSCLC proliferation, apoptosis and metastasis, including impacts on cell stemness via sphere formation. In vivo xenograft and liver metastasis models show BHB reduces viability, stemness, migration and invasion while suppressing tumor growth and metastasis. Mechanistically, FFAR3 knockdown and overexpression respectively abrogate and enhance BHB’s anti-tumor activity, identifying FFAR3 as a key mediator.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/hydroxybutyrate-a-ketone-body-suppresses-tumor-growth-stemness-and-invasive-phenotypes-in-non-small-cell-lung-cancer/368092/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/hydroxybutyrate-a-ketone-body-suppresses-tumor-growth-stemness-and-invasive-phenotypes-in-non-small-cell-lung-cancer/368092.png","ImageObject",300,407,{"name":92,"@type":93},"pixelkiddo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-17","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main research question about beta-hydroxybutyrate (BHB) in NSCLC?","Question",{"text":113,"@type":114},"Whether BHB mediates NSCLC progression, particularly effects on tumor growth, stemness, and invasive and metastatic phenotypes.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were BHB effects on NSCLC cells evaluated?",{"text":118,"@type":114},"The study assessed proliferation, apoptosis, migration and invasion using CCK-8, flow cytometry, western blotting and Transwell assays, and measured stemness using a sphere formation assay.",{"name":120,"@type":111,"acceptedAnswer":121},"What role does FFAR3 play in BHB’s anti-tumor effects?",{"text":122,"@type":114},"FFAR3 knockdown abolished BHB’s tumor-suppressive effects, while FFAR3 overexpression enhanced them, identifying FFAR3 as a key mediator.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},368092,1790197144,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},962090883892,"https://ap-avatar.wpscdn.com/avatar/e00115db34f3e0f11b?x-image-process=image/resize,m_fixed,w_180,h_180&k=1790152879550218658","CANCER BIOLOGY & THERAPY  \n2025, VOL. 26, NO. 1, 2516825 [https://doi.org/10.1080/15384047.2025.2516825](https://doi.org/10.1080/15384047.2025.2516825)  \nRESEARCH PAPER  \nβ-hydroxybutyrate, a ketone body, suppresses tumor growth, stemness, and invasive phenotypes in non-small cell lung cancer  \nYunlong Huang a*, Jiaxuan Dingb*, Yufeng Zhuc, Jin Shic, Rong Liua, Chunmei Wua, Liangfu Hana, and Mingfeng Zhangd  \naDepartment of Oncology, Foshan Fosun Chancheng Hospital, Foshan, China; bDepartment of Radiation Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; cNanfang Hospital, Southern Medical University, Guangzhou, China; dDepartment of Oncology, Sun Yatsen Memorial Hospital of Sun Yat-sen University, Guangzhou, China  \nABSTRACT  \nLung cancer is the most common cancer worldwide. The stemness and metastasis of tumor cells present major challenges to effective lung cancer treatment. Beta-hydroxybutyrate (BHB), a ketone body, plays a key role in various cancers. However, whether BHB mediates the progression of non-small cell lung cancer (NSCLC) remains unclear. The effects of BHB on the proliferation, apoptosis, and metastasis of NSCLC cells were assessed using the Cell Counting Kit 8, flow cytometry, western blotting, and Transwell assays. The sphere formation assay was used to evaluate the impact of BHB on NSCLC cell stemness. The underlying molecular mechanism was investigated through knockdown and overexpression of free fatty acid receptor 3 (FFAR3) using shRNAs and expression vectors in two NSCLC cell lines (NCI-H1975 and PC- 9) . In vivo, xenograft tumor and liver metastasis models were established in nude mice. BHB treatment reduced viability, stemness, and migratory and invasive abilities of NSCLC cells. BHB also induced apoptosis and increased cleaved caspase-3 levels in these cells. Moreover, BHB suppressed tumor growth and metastasis, and reduced cell stemness in NSCLC tissues in vivo. Mechanistically, FFAR3 knockdown abolished, while FFAR3 overexpression enhanced, the tumor-suppressive effects of BHB, identifying FFAR3 as a key mediator. These data shed light on the role of BHB in NSCLC development and its underlying molecular mechanisms, suggesting a promising treatment strategy for patients with NSCLC.  \nARTICLE HISTORY  \nReceived 9 December 2024 Revised 24 April 2025 Accepted 2 June 2025  \nKEYWORDS  \nBeta-hydroxybutyrate; nonsmall cell lung cancer; stemness; metastasis; FFAR3  \nIntroduction  \nDue to worsening atmospheric conditions, lung cancer has become one of the most prevalent malignant tumors worldwide, with approximately 85% of cases classified as non-small cell lung cancer (NSCLC) . 1,2 The development of targeted drugs and immunotherapy has significantly improved NSCLC treatment outcomes. However, the emergence of drug resistance and early metastasis severely undermines the efficacy of treatment.3,4 NSCLC metastasis is a complex, multistep process.5 It has been reported that > 50% of patients with NSCLC develop local or remote metastases, with only 15% of them surviving for five years or longer following tumor metastasis.6 Metastatic NSCLC cells are known to spread to various organs, including bone, brain, and liver.7 Additionally, cancer stem cells (CSCs) play a critical role in tumor metastasis. Cancer stemness is considered a key factor in the metastatic process.8–10 Although the origin and definition of CSCs remain under investigation, researchers have shown that the activation of cell stemness is related to tumorigenesis.11 The stem-like state of cancer cells enhances their self-renewal capacity and allows a small number of cells to proliferate into  \ntumor tissue, thereby accelerating the dissemination and recurrence of tumors.12 Cancer cell stemness and metastasis are interconnected processes that regulate the occurrence and progression of cancer. 13 Therefore, understanding the mechanisms underlying cell stemness and metastasis in NSCLC is essential for improving treatm","cbCailxTuLspP1Ct","https://ap.wps.com/l/cbCailxTuLspP1Ct","pdf",12271493,14,"English","# Introduction\n## Background on NSCLC, metastasis, and cancer stemness\n## Ketogenic diet and BHB rationale\n# Materials and Methods\n## Cellular assays (viability, apoptosis, migration/invasion, stemness)\n## Molecular mechanism (FFAR3 knockdown/overexpression)\n## In vivo xenograft and metastasis models\n# Results\n## BHB reduces NSCLC viability, stemness, and invasive phenotypes\n## BHB induces apoptosis and activates caspase-3\n## FFAR3 mediates BHB anti-tumor effects\n# Discussion\n## Mechanistic implications and therapeutic potential","[{\"question\":\"What is the main research question about beta-hydroxybutyrate (BHB) in NSCLC?\",\"answer\":\"Whether BHB mediates NSCLC progression, particularly effects on tumor growth, stemness, and invasive and metastatic phenotypes.\"},{\"question\":\"How were BHB effects on NSCLC cells evaluated?\",\"answer\":\"The study assessed proliferation, apoptosis, migration and invasion using CCK-8, flow cytometry, western blotting and Transwell assays, and measured stemness using a sphere formation assay.\"},{\"question\":\"What role does FFAR3 play in BHB’s anti-tumor effects?\",\"answer\":\"FFAR3 knockdown abolished BHB’s tumor-suppressive effects, while FFAR3 overexpression enhanced them, identifying FFAR3 as a key mediator.\"}]","β-hydroxybutyrate, a ketone body, suppresses tumor growth, stemness, and invasive phenotypes in non-small cell lung cancer | PDF",1790174963,35,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b71cd9d70b24f89d8241b9b16c5d9f74.webp",983,1280,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fb18f0df5856d4e098e4e1ec70df5200.webp",982,1278,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/130880c0d27f45a0ea113f5b38232ca7.webp",981,1277,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/83683fcbc137913f5d012099794b95cd.webp",980,1276]